Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

362 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management.
van Leeuwen RWF, le Comte M, Reyners AKL, van den Tweel A, van Vlijmen B, Kwee W, Wensveen B, Steeghs N, Visser O, van Gelder T, Jansman FGA. van Leeuwen RWF, et al. Among authors: visser o. Semin Oncol. 2022 Apr;49(2):119-129. doi: 10.1053/j.seminoncol.2022.03.002. Epub 2022 Mar 30. Semin Oncol. 2022. PMID: 35397932 Free article. Review.
[Taste and smell changes resulting from cancer therapies].
Huisman F, Van Elst JM, Reyners AKL, De Haan JJ, Oei M, Visser O, Kramer EPA. Huisman F, et al. Among authors: visser o. Ned Tijdschr Geneeskd. 2021 Dec 21;165:D5696. Ned Tijdschr Geneeskd. 2021. PMID: 35129889 Dutch.
Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors.
Boekel NB, Schaapveld M, Gietema JA, Russell NS, Poortmans P, Theuws JC, Schinagl DA, Rietveld DH, Versteegh MI, Visser O, Rutgers EJ, Aleman BM, van Leeuwen FE. Boekel NB, et al. Among authors: visser o. Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1061-72. doi: 10.1016/j.ijrobp.2015.11.040. Epub 2015 Dec 14. Int J Radiat Oncol Biol Phys. 2016. PMID: 27026313
Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Pal HJ, Loonen JJ, Bresters D, Versluys B, Neggers SJCMM, Jaspers MWM, Hauptmann M, van der Heiden-van der Loo M, Visser O, Kremer LCM, Ronckers CM; DCOG LATER Study Group. Teepen JC, et al. Among authors: visser o. J Clin Oncol. 2017 Jul 10;35(20):2288-2298. doi: 10.1200/JCO.2016.71.6902. Epub 2017 May 22. J Clin Oncol. 2017. PMID: 28530852
Taste alterations and cancer treatment.
van Oort S, Kramer E, de Groot JW, Visser O. van Oort S, et al. Among authors: visser o. Curr Opin Support Palliat Care. 2018 Jun;12(2):162-167. doi: 10.1097/SPC.0000000000000346. Curr Opin Support Palliat Care. 2018. PMID: 29570496 Review.
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M, Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW, Roesink J, Raemaekers JM, de Boer JP, Zijlstra JM, van Imhoff GW, Petersen EJ, Poortmans PM, Beijert M, Lybeert ML, Mulder I, Visser O, Louwman MW, Krul IM, Lugtenburg PJ, van Leeuwen FE. Schaapveld M, et al. Among authors: visser o. N Engl J Med. 2015 Dec 24;373(26):2499-511. doi: 10.1056/NEJMoa1505949. N Engl J Med. 2015. PMID: 26699166 Free article.
Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era.
Dinnessen MAW, Maas CCHM, Tonino SH, Visser O, Posthuma EFM, Blijlevens NMA, Kersten MJ, Lugtenburg PJ, Dinmohamed AG. Dinnessen MAW, et al. Among authors: visser o. Leukemia. 2022 May;36(5):1416-1420. doi: 10.1038/s41375-022-01535-y. Epub 2022 Mar 4. Leukemia. 2022. PMID: 35246605 No abstract available.
362 results